Last reviewed · How we verify
Forest Pharmaceuticals Inc's Bystolic Tablets — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Forest Pharmaceuticals Inc's Bystolic Tablets (Forest Pharmaceuticals Inc's Bystolic Tablets) — Torrent Pharmaceuticals Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Forest Pharmaceuticals Inc's Bystolic Tablets TARGET | Forest Pharmaceuticals Inc's Bystolic Tablets | Torrent Pharmaceuticals Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Forest Pharmaceuticals Inc's Bystolic Tablets CI watch — RSS
- Forest Pharmaceuticals Inc's Bystolic Tablets CI watch — Atom
- Forest Pharmaceuticals Inc's Bystolic Tablets CI watch — JSON
- Forest Pharmaceuticals Inc's Bystolic Tablets alone — RSS
Cite this brief
Drug Landscape (2026). Forest Pharmaceuticals Inc's Bystolic Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/forest-pharmaceuticals-inc-s-bystolic-tablets. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab